Probiotic may prevent colic in healthy infants: BioGaia study

- Last updated on GMT

Related tags: Gastroenterology, Infant

Probiotic may prevent colic in healthy infants: BioGaia study
Supplementation with the probiotic Lactobacillus reuteri Protectis may help prevent the onset of functional gastrointestinal disorders such as colic in healthy infants, according to new research backed by probiotic player BioGaia.

The study, published in JAMA Pediatrics​, investigated whether oral supplementation with Lactobacillus reuteri​ DSM 17938 (L. reuteri​ Protectis) had any effect on the onset of colic, gastroesophageal reflux, and constipation in full-term newborns, and whether any benefit from supplementation could also reduce the socioeconomic impact of these conditions.

Led by DrFlavia Indrio from the University of Bari, Italy, the research team recruited 589 infants to the randomised, double-blinded, placebo-controlled multicentre trial for a total of three months - finding that infants given the prophylactic probiotic cried less than half as long as infants given a placebo. In addition the team revealed that those infants given the probiotic strain had significantly fewer daily regurgitations and were less constipated compared to infants in the placebo group.

Further investigation in to the economic impact of these benefits revealed that the supplementation was responsible for savings of €88 for the family and €104 for the community - leading the team to conclude that the use of L reuteri​ DSM 17938 was a 'cost-effective' strategy to reduce infant gastrointestinal disorders such as colic, and its associated healthcare costs.

“This is the first study proving prophylactic use of a specific strain (​L. reuteri Protectis) in a condition like functional gastrointestinal disorders (colic, regurgitation and constipation),"​ commented Indrio.

"Moreover this is also the first evaluation of the cost/benefit for a probiotic therapy in infants and it shows that ​L. reuteri Protectis is valuable for the family and for the society,”​ he added.

Probiota 2014

Invested in pre- and probiotics? Probiota 2014 will explore the prebiotic-probiotic scientific frontier, its evolution and commercial application in food, nutraceuticals, pharmaceuticals and cosmetics across the globe.

The 2-day, 2-stream event – formerly Probiotech and Microbiota - will be held in Amsterdam on February 4-5 this year. Will you be joining your peers there?

To know more click here​.

Related news

Related products

show more

Next Generation Prebiotic Solution

Next Generation Prebiotic Solution

Deerland Probiotics & Enzymes | 23-Sep-2019 | Product Presentation

There’s an entire ecosystem going on in your gut. Good bacteria need room to live and grow, but harmful bacteria can take over and rob your body of the...

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Probiotics for Sports Nutrition

Probiotics for Sports Nutrition

Deerland Probiotics & Enzymes | 21-Jun-2019 | Application Note

A healthy gut and improved immune system are key factors to help overtake the competition. For athletes and fitness enthusiasts, optimizing digestion and...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars